Press Release Nicox Announces Approval of ZERVIATE in China Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China ...

A high-level overview of Harrow, Inc. NT CAL 27 (HROWM) stock. View (HROWM) real-time stock price, chart, news, analysis, analyst reviews and more.

ZERVIATE is the first and only eye drop formulation of the antihistamine cetirizine, the active ingredient in ZYRTEC ®, and is currently commercialized in the U.S. for ocular itching associated ...

Learn about the many types of eye drops available for treating dry eye syndrome. Over-the-counter options are often effective, and prescription options are available if they aren't.

Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that its exclusive Chinese partner, Ocumension Therapeutics, has received approval of ...

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that the New Drug Application (NDA) for approval to commercialize ZERVIATE ® (cetirizine ...

Press Release Nicox Announces Approval of ZERVIATE in China Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China will add ...

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that the New Drug Application (NDA) for approval to commercialize ZERVIATE ® (cetirizine ...